GRHL3 and cancer: Since opposing functions of GRHL3 depending on cancer type and/or differentiation status have been demonstrated in previous studies of other cancer entities [6, 8], we aimed to characterize for the first time GRHL3 expression, function and associated molecular downstream targets and pathways in urothelial versus squamous‐differentiated bladder cancer.